Off-label use of becaplermin gel (recombinant platelet-derived growth factor-BB) for treatment of mucosal defects after corticocancellous bone graft: report of 2 cases with review of the literature.
Calhoun
Colonya C
CC
Division of Oral and Maxillofacial Surgery, Harbor/University of California, Medical Center, Torrance, CA 90509, USA. cccal69@aol.com
Cardenes
Omel
O
Ducksworth
Joseph
J
Le
Anh D
AD
D000293:Adolescent; D000540:Alveolar Ridge Augmentation; D043925:Angiogenesis Inducing Agents / Q000627:therapeutic use*; D000077214:Becaplermin; D016025:Bone Transplantation / Q000473:pathology; D004348:Drug Labeling; D006085:Graft Survival / Q000187:drug effects / Q000502:physiology; D006801:Humans; D008297:Male; D008334:Mandible / Q000473:pathology / Q000601:surgery*; D013516:Oral Surgical Procedures, Preprosthetic / Q000379:methods; D010982:Platelet-Derived Growth Factor / Q000627:therapeutic use*; D020574:Proto-Oncogene Proteins c-sis; D011994:Recombinant Proteins; D013524:Surgical Flaps / Q000098:blood supply / Q000473:pathology*; D013529:Surgical Wound Dehiscence / Q000188:drug therapy*; D016896:Treatment Outcome; D014945:Wound Healing / Q000187:drug effects* / Q000502:physiology; D055815:Young Adult
D043925:Angiogenesis Inducing Agents; D010982:Platelet-Derived Growth Factor; D020574:Proto-Oncogene Proteins c-sis; D011994:Recombinant Proteins; D000077214:Becaplermin